Prostate Cancer in Renal Transplant Recipients: Results from a Large Contemporary Cohort.
Giancarlo MarraFrancesco SoriaFederica PerettiMarco OderdaCharles DarianeMarc-Olivier TimsitJulien BranchereauOussama HedliBenoit MesnardDerya TilkiJonathon OlsburghMeghana KulkarniVeeru KasivisvanathanCedric LebacleOscar Rodriguez-FabaAlberto BredaTimo SoeterikGiorgio GandagliaPaola TodeschiniLuigi BianconePaolo Gonteronull On Behalf Of The CollaboratorsPublished in: Cancers (2022)
PCa diagnosed in RTRs is mainly of low to intermediate risk and organ-confined at diagnosis, with good cancer control and low PCa death at intermediate follow-up. RTRs have a non-negligible risk of death from causes other than PCa. Aggressive upfront management of the majority of RTRs with PCa may, therefore, be avoided.